X4 Pharmaceuticals

XFOR

Börsenwert 325 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	14,2 Mio. $	+774.254 $	+31.839	+6 %
2	2 NEA Management Company Timonium, Maryland	12,6 Mio. $	–	–	–
3	3 BlackRock New York	7,06 Mio. $	+211.297 $	+8.689	+3 %
4	4 Vanguard Group Malvern, Pennsylvania	6,72 Mio. $	+149.263 $	+6.138	+2 %
5	5 OrbiMed New York	5,98 Mio. $	–	–	–
6	6 Adage Capital Partners Boston, Massachusetts	3,59 Mio. $	–	–	–
7	7 Sio Capital Management New York	3,01 Mio. $	+802.025 $	+32.981	+38 %
8	8 Perceptive Advisors New York	2,97 Mio. $	–	–	–
9	KCM 9 Kingdon Capital Management New York	2,91 Mio. $	+1,22 Mio. $	+50.000	+76 %
10	10 Axa Paris, France	2,58 Mio. $	-60.260 $	-2.478	-2 %
11	11 Geode Capital Management Boston, Massachusetts	2,35 Mio. $	+129.322 $	+5.318	+6 %
12	12 State Street Boston, Massachusetts	2,04 Mio. $	+39.833 $	+1.638	+2 %
13	13 Armistice Capital New York	1,62 Mio. $	-340.449 $	-14.000	-18 %
14	14 UBS O'Connor Chicago, Illinois	1,46 Mio. $	+148.363 $	+6.101	+12 %
15	15 Citadel Advisors Miami, Florida	1,45 Mio. $	-57.195 $	-2.352	-4 %
16	16 Millennium Management New York	1,4 Mio. $	-1,58 Mio. $	-65.055	-54 %
17	17 Northern Trust Chicago, Illinois	891.313 $	-3.818 $	-157	-0,4 %
18	18 GSA Capital Partners London, United Kingdom	793.000 $	+262.292 $	+10.786	+52 %
19	19 Parkman Healthcare Partners Stamford, Connecticut	643.408 $	-26.482 $	-1.089	-4 %
20	20 Point72 Asset Management Stamford, Connecticut	545.025 $	–	–	–
21	21 Schonfeld Strategic Advisors New York	460.586 $	-29.789 $	-1.225	-6 %
22	22 Propel Bio Management Los Angeles, California	448.598 $	+433.659 $	+17.833	Neu
23	23 Barclays London, United Kingdom	444.070 $	+119.522 $	+4.915	+39 %
24	HCAL 24 HURRICANE CAPITAL ADVISORS LLC New York	420.484 $	+406.496 $	+16.716	Neu
25	25 Nuveen Charlotte, North Carolina	367.358 $	–	–	–

X4 Pharmaceuticals XFOR Börsenwert 325 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 325 Mio. $